In the Drosophila CNS, both neurons and glia are derived from neuroblasts. We have identified a gene, 
Introduction
One of the major challenges in developmental biology is to understand how cellular diversity is created. A theoretically possible mechanism would be to determine two cell fates by the presence or absence of a single switch molecule. The nature of such a gene was clearly foretold by Waddington (1940) . To define such a switch molecule experimentally, we require three pieces of evidence. First, the presence of the molecule is restricted to the cells that are to be "turned on." Second, in the absence of the molecule, all cells follow the "default" fate. Third, the ectopic presence of the molecule turns on all cells to the "alternative" fate. Under these criteria, only a few molecules have been shown to act as binary switches in major cell fate decisions. Here we report our findings of an additional gene in this class in Drosophila, one which functions as a binary switch to determine whether cells in the nervous system follow one of the two differentiation pathways, neuronal or glial.
The Drosophila nervous system is a highly sophisticated model system for developmental neurobiology, with its well-characterized anatomy and powerful genetic techniques (reviewed by Goodman and Doe, 1993) . The neurogliogenesis of the embryonic central nervous system (CNS) begins in the neuroectoderm with the invagination of about 29 identified neuroblasts and one glioblast (the *Present address: Molecular Genetics Laboratory, University of Tokyo, Tokyo 113, Japan.
longitudinal glioblast [LGB] ) per hemisegment. The neuroblasts generate several ganglion mother cells, each of which then divides to become two neurons. It was recently shown that some neuroblasts also produce glial cells. The neuroblast NBI-1 first generates two identified neurons, aCC and pCC. In abdominal segments, NBI-1 then generates three glial cells, including the A and B glial cells plus a cluster of neurons, indicating that NBI-1 is a neuroglioblast (Udolph et al., 1993) . It is also strongly suggested that the abdominal N B6-4 divides symmetrically to produce the VUM support glial cell and a cell body gila (S. Higashijima et al., personal communication) . In addition to these gilaproducing neuroblasts, the LGB divides several times to produce six to eight glial cells that constitute majority of the longitudinal glial cells (Doe et al., 1988; Goodman and Doe, 1993; Ito et al., 1995) . The origins of other glial cells are mostly unknown, but they are likely to be derived from the ectodermal neuroblasts. In addition to these ectodermal cells, the mesectodermal precursors generate midline gila and additional neurons. The mature em bryonic CNS consists of about 200 neurons and 24-28 ectodermal glial cells per hemisegment plus a small number of mesectodermal midline gila. Many neurons and most of the glial cells have been identified by their locations, morphology, and gene expression patterns (e.g., reviewed by Goodman and Doe, 1993 ; for glial mappings and nomenclature, see also Kl&mbt and Goodman, 1991 ; Ito et al., 1995) .
Extensive genetic analyses have identified a number of genes involved in cell fate specification in the CNS. Among them, several genes, including elav, pointed, and repo (also known as rk2), are expressed either in neurons or in glial cells exclusively and have functions in differentiation steps specific for the corresponding cell types (e.g., Robinow and White, 1988; Kl&mbt, 1993; Klaes et al., 1994; Xiong et al., 1994; Campbell et al., 1994; Halter et al., 1995) . However, none of the previously identified genes have been shown to be involved in neuronal/glial determination.
The mutant we isolated is named glial cells missing (gcm) based on the initial finding that ectodermal glial cells are entirely absent. The gcm gene encodes a novel nuclear protein. First, we have shown that gcm is expressed exclusively in all ectodermal glial cells at the earliest stages. Second, in gcm loss-of-function mutant, the presumptive glial cells differentiate into neurons. Third, under gcm ectopic expression, virtually all CNS cells differentiate into glial cells. These results indicate that gcm functions as a binary switch in neuronal/glial determination. We also obtained consistent results in the peripheral nervous system (PNS), showing glial/neuronal determination in the PNS is also governed by the gcm gene.
We obtained further insights in differentiation and functions of glial cells by examining the gcm phenotype. We have shown that the "pioneer neurons" can find their correct pathways independent of the presence of glial cells, while other follower axons show defects in fasciculation and pathfinding in the mutant nervous system. We also found that the presumptive glial cells that had transformed into neurons in gcm mutants behave in a stereotyped and reproducible manner, suggesting that each individual glial cell is transformed to a neuron with unique characteristics. Thus, we would like to suggest that neurons and glial cells have a common molecular mechanism for the determination of individual identity. During the preparation of our manuscript, we noticed that groups from the Bellen and Goodman laboratories had also identified the same gene. We have agreed to use the name glial cells missing (gcm). These two groups present results essentially consistent with ours supporting validity of our conclusions (Kania et al., 1995; Jones et al., 1995 [this issue of Cell] ).
Results

Isolation of gcm Mutants with Defects in the Embryonic Nervous System
The mutant gcm was isolated in our enhancer detector screening designed to identify genes involved in cell fate determination in the embryonic CNS. We generated 100 lethal strains by insertion of P elements carrying the enhancer detector gene, lacZ. We screened these strains first for lacZ expression in the CNS to isolate candidate genes involved in CNS development. From these isolated strains, we screened for defects in CNS development by staining the axonal tracts with an antibody against horseradish peroxidase (HRP), which stains all neuronal cell surfaces, including axons (Jan and Jan, 1982) . The original gcm allele, gcm P, showed serious defects in the formation of CNS axonal tracts. In vivo excisions of the P element generated three revertants and 17 lethal alleles with varied severity in axonal phenotype, indicating that the gcm chromosome has no other lethal mutations and that the gcm gene is in the vicinity of the P element insertion. Among them, gcm I had the most severe axonal defects. The longitudinal tracts of this allele have much fewer axons than normal in approximately 40% of the hemisegments (compare Figure 1A with Figure 1B ). The transverse commissures are sometimes fuzzy. The gcm locus was mapped to cytogenetic position 30C on the second chromosome by in situ hybridization to polytene chromosomes. The mutant did not complement the lethality of Df(2L)3OA;C, a chromosome that has deficiency at 30A-30C (Lindsley and Zimm, 1992) .
To clone the gcm gene, we first isolated a genomic fragment adjacent to the P element insertion from the mutant genomic library and then cloned the wild-type genomic DNA around it (Figure 2A ). By in situ hybridization and by Northern blot analysis, we searched a 15 kb genomic DNA for sequences transcribed in the embryonic CNS. Both analyses detected only one transcription unit adjacent to the insertion point ( Figure 2A ). Screening of a cDNA library of an early embryonic stage using this region as a probe resulted in the isolation of several cDNA clones. The longest clone was 2 kb, consistent with the results of Northern blot analysis. The 5' end of the cDNA was mapped 5 bp downstream of the insertion point (Figure 2A Figure 2A .
By in situ hybridization to embryos, we examined whether gcm mutants express the isolated gene. In normal embryos heterozygous for gcm' and a balancer chromosome, mRNA of the gene is detected in the CNS neurogenic region (brown spots in Figure 1C ), in addition to the blue stripes that are the reaction product generated by the lacZ gene on the balancer chromosome indicating heterozygosity. In contrast, mRNA of the gene was not detected in homozygous gcm' embryos (Figure 1 D) . We also found that embryos homozygous for gcm P express no detectable mRNA of the gene, although they have a slightly milder axonal phenotype than gcmt These results indicate that the isolated gene is gcm. Because these two alleles, gcm ~ and gcm p, express no detectable gcm mRNA, we used them for further phenotype analysis. Since both alleles have intact gcm coding regions, we cannot exclude a possibility that these alleles express very small amount of normal gcm protein.
The gcm Gene Encodes a Novel Nuclear Protein
The 1960 bp gcm cDNA contains an open reading frame of 504 amino acids ( Figure 2B ). The predicted amino acid sequence of the gcm cDNA has a distinct nuclear targeting sequence, (KJR)2-Xlo-(K/R)3_s (Dingwall and Laskey, 1991) , shown by double underlining in Figures 2B and 2C . Other than the nuclear targeting sequence, gcm showed no significant homology with any known proteins. Thus, gcm is most likely a nuclear protein of a novel class.
One remarkable feature of the protein is that most basic residues are located in the N-terminal half, comprising several basic regions ( Figure 2C ). On the other hand, acidic residues are distributed evenly throughout the protein ( Figure 2C ). Gcm has a highly basic cysteine-dch region (single underlining in Figures 2B and 2C ). Gcm also has one PEST-like sequence, which may function as a signal for rapid degradation (Rogers et al., 1986) , and three repeats of a sequence MPVP in the N-terminal region (both indicated by broken double underlining in Figure 2B ). Homopolymeric stretches of glutamine, serine, glycine, and tyrosine residues are found in the C-terminal half of the protein (broken single underlining in Figure 2B ). The open reading frame has two candidate initiation methio- Figure 2B ), whose preceding nucleotide sequence matches the proposed translation initiation sequence, (C/A)AA(A/C) (Cavener, 1987) . The 3' untranslated region carries an mRNA instability motif, AUUUA (Shaw and Kamen, 1986) .
nines (italicized in
Expression of gcm in Glial Cells at Early Stages
We investigated gcm expression by in situ hybridization to embryos. In the embryonic CNS, we found that the expression of gcm mRNA is located in glial precursors and immature glial cells during a short period of gliogenesis. In the CNS, gcm mRNA is first detected in one cell per hemisegment at early stage 11 ( Figure 3A ; staging is according to Campos-Ortega and Hartenstein, 1985). This cell is the LGB, located in the most lateral position in the neurogenic region medial to the segmental furrow. At midstage 11, LGB divides symmetrically (thin arrowheads in Figure 3B) judged by its location and behavior of the progeny. Just after it expresses gcm, NB6-4 divides symmetrically; then, one of the progeny, the presumptive VUM support glial cell, migrates medially, gcm mRNA is detected in the migrating presumptive VUM support glial cell (closed arrows in Figure 3C ). The other one or two gcm-positive cells located around the anterior border of the segment (open arrow in Figure 3B ) correspond to the immature glial cell(s) reported by Halter et al. (1995) (see Figure 4B in Halter et al., 1995) . At early stage 12, gcm mRNA is detected in several other cells (see Figure 3C ). Expression patterns in those cells match that of developing glial cells (Xiong et al., 1994; Campbell et el., 1994; Halter et al., 1995) . The expression fades during stage 12 and is hardly detected at stage 13, when most of the glial cells have become postmitotic (Campbell et ai., 1994; Halter et al., 1995) .
We traced these gcm-positive cells to later developmental stages by marking them with the enhancer detector lacZ on the gcm p chromosome. The lacZ protein of the gcm p chromosome, diffuses into whole cell bodies to make entire cell morphology visible. We found that the gcmPl+ embryos express lacZ essentially in the same pattern as gcm mRNA (compare Figure 3E with Figure 3B ), indicating that gcm-positive cells coexpress lacZ on the gcm p chromosome. Since lacZ protein is stable in Drosophila embryos, it is detected in virtually all the ectodermal glial cells at a later stage ( Figure 4C ). We could detect neither gcm mRNA nor lacZ expression in the midline region (large arrowheads in Figures 3A-3C and 3E), indicating that neither is expressed in the midline glial cells, which are derived from the mesectoderm. These results indicate that gcm is expressed in all glial precursors and immature glial cells except those derived from the mesectoderm.
In the brain neurogenic region, we also detected gcm mRNA expression during stage 11 (data not shown). In the larval brain, gcm enhancer trap lacZ is expressed in the optic lobe from late second instar to third instar (data not shown), when gliogenesis takes place (Winberg et al., 1992) . It is very likely that these gcm-or lacZ-positive cells in the brain are glial precursors and immature glial cells.
At stage 10, gcm mRNA is detected in the PNS neurogenic region of each segment ( Figure 3D ). This expression ceases at the beginning of stage 11. In gcmPl+ embryos, lacZ protein is detected in PNS neurogenic region in the same pattern as that of gcm mRNA. At later stages in the PNS, lacZ is detected in a subset of glial cells such as ligament cells of the chordotonal organ, support cells of dorsal bipolar dendritic cells, and peripheral glial cells (data not shown).
Besides the neurogenic regions, gcm is also expressed 
Mutation of gcm Transforms CNS Glial Cells into Neurons
Since the expression pattern suggested an involvement of gcm in early glial differentiation, we first investigated glial cell divisions in the mutant. We used lacZ protein produced by the gem P chromosome to visualize glial cells in the mutant. In the gcmPlgcm p mutant embryos, in which gcm mRNA expression is hardly detectable, the initial lacZ pattern is almost normal (compare Figure 3F with 3El. The final number of lacZ-positive cells is about 25, almost the same as that of normal ectodermal glial cells (24-28). Until early stage 12, the locations of these lacZ-positive cells in the mutant are very similar to the locations of lacZ-positive glial cells in normal gcmPl+ embryos. Thus, in gem mutants, the initial divisions of the presumptive glial cells are essentially normal, and these cells express the enhancer detector lacZ as in normal embryos.
To examine differentiation of mutant glial cells, we studied expression of a glial-specific protein, repo. Repo is a homeodomain protein, required for glial differentiation, that is expressed in all CNS glial cells except in the mesectodermal midline gila (Xiong et al., 1994; Campbell et al., 1994; Halter et al., 1995) . Repo expression begins at early stage 11 in the glial progenitors and immature glial cells and then lasts to the end of embryonic development. Figures 4A and 4B show photographs of late embryos stained with anti-repo antibody. In normal embryos, most of the glial cells except the midline gila express repo ( Figure 4A ). In gcm ~ embryos, virtually no cells express repo ( Figure  4B ). In gcmPlgcm p mutant embryos, only a few of the lacZpositive cells express repo in each hemisegment. This leakage expression is rather stochastic, but it is apparently all or none. The mutant glial cells do not express repo even at earlier stages. On the other hand, gcm mRNA expression is normal in repo 3 mutant, a putative null allele of repo (Xiong et al., 1994; Halter et al., 1995) , indicating that gcm is epistatic to repo (data not shown). We also examined expression of a putative transcription factor protein, prospero (pros). In normal embryos, pros is expressed in a subset of neurons and a subset of glial cells, including the longitudinal gila (Doe et al., 1991) . In gcm 1 embryos, pros expression in neurons is almost normal, whereas its expression in glial cells is absent (data not shown).
We further investigated the fate of the mutant glial cells. In normal gcm~l+ embryos, the lacZ-positive presumptive Figure 4C ). In gcmPIgcm P mutant embryos, the lacZ-positive presumptive glial cells fail to migrate to normal positions ( Figure  4D ). Their cell bodies have a round shape typical of neurons. We found that most of these lacZ-positive cells send out axons. At stage 14, lacZ-positive axon bundles running across the midline are visible in every segment (open and closed arrows and arrowhead in Figure 4D ). This axonal lacZ expression is not simply caused by the increase of lacZ gene dosage in gcmPIgcm P, because the same results were obtained with embryos heterozygous for g c m p and g c m 1, the latter of which express no detectable lacZ. By examining a number of hemisegments, we obtained the following results. First, the number of lacZ-positive cells in the mutant is about 25 per hemisegment, almost the same as that of the normal ectodermal glial cells (24) (25) (26) (27) (28) . Second, at least 21 lacZ-positive cells send out axons. Third, the axonal extension pattern is highly stereotyped and reproducible, not only from individual to individual, but from segment to segment, with minor differences between thoracic and abdominal segments ( Figure 4D ; see the legend for details). Thus, it is strongly suggested that in g c m mutants the lacZ-positive presumptive glial cells differentiate into neurons with unique characteristics.
The g c m mutants also show general phenotype common to glial mutants. Normal CNS neuromere shortens at the end of the embryonic development, whereas the mutant CNS remains elongated (data not shown). This condensation defect has also been seen in other mutants with glial defects, such as p r o s and repo (Doe et al., 1991; Xiong et al., 1994; Campbell et al., 1994; Halter et al., 1995) . The contour of the mutant neuromere is irregular compared with normal embryos (Figures 4A and 4B ). The repo mutant shows a similar phenotype (Halter et al., 1995) .
The mesectodermal midline gila express neither g c m nor repo. We investigated their cell fate using an enhancer trap strain AA142, which expresses lacZ in midline gila (Kl&mbt et al., 1991) . AA142 stained normal number of cells in g c m ~ background, indicating that g c m mutation does not affect midline gila (data not shown).
Mutation of gcm Transforms PNS Glial Cells into Neurons
In the normal PNS, repo is expressed in gcm-positive glial cells: the ligament cells of the lateral pentascolopidial chordotonal organ (LCH5), the support cells of the dorsal bipolar dendritic cell, and the peripheral glial cells ( Figure  5A ; Xiong et al., 1994; Campbell et al., 1994; Halter et al., 1995) . In g c m mutants, repo expression in these PNS glial cells is not detected (Figure 5B Figure 1A ). All embryos are at stage 15. Anterior is up. Scale bar, 30 I~m.
We further investigated fate of the ligament cells. The LCH5 is comprised of five chordotonal organs. Each chordotonal organ is comprised of one neuron and three glial cells: the ligament cell, cap cell, and scolopale. These four cells are derived from a single sensory organ precursor (Bodmer et al., 1989) . We stained all cell nuclei of the PNS with an antibody against the couch potato (cpo) protein (Bellen et al., 1992) . In normal embryos, five roundshaped nuclei of neurons (closed arrow in Figure 5C ) and five thin-shaped nuclei of ligament cells (arrowhead in Figure 5C ) are stained in two rows in the ventral half of the chordotonal organ. In gcm mutants, 10 round cells are visible at the ventral part of the chordotonal organ (open arrow in Figure 5D ), indicating that the mutant ligament cells are transformed to cells indistinguishable from neurons.
In normal LCH5, the five neurons express a neuronspecific protein, elav ( Figure 5E ; Robinow and White, 1988) . In gcm ~ embryos, 15% (7 of 48) of chordotonal organs showed increase in elav-positive cells. Figure 5F shows an extreme case in which 10 elav-positive cells are visible, indicating that all the five ligament cells are transformed into elav-positive neurons. These results indicate that gcm mutation transforms repo-positive glial cells to neurons in the PNS as well as in the CNS.
Ectopic Expression of gem Transforms Neurons into Glial Cells
To investigate the effect of gcm ectopic expression in neuronal cells, we used the GAL4-UAS system (Brand and Perrimon, 1993) . The gcm cDNA was subcloned into the polycloning site of the pUAST vector and was then introduced into flies by germline transformation to establish UAS-gcm flies. The UAS-gcm flies were crossed to the scaGAL strain (Klaes et al., 1994) , which carries a transgenic GAL4 gene driven by the promoter of a neurogenic gene, scabrous (sca) (Mlodzik et al., 1990) . In sca-GAL; UAS-gcm embryos, GAL4 protein is expressed in all the neuroblasts and their progeny (Klaes et al., 1994) and then binds to the upstream activation sequences (UASs) in the pUAST vector to activate the recombinant gcm gene.
We first found that in these scaGAL; UAS-gcm embryos, all the neuroblasts become repo positive (data not shown). At stage 15, approximately 8 0 0 -9 0 % of CNS cells express repo ( Figure 6A ; compare with a normal embryo shown in Figure 4A ). Most of these repo-positive cells have elongated or irregular cell shapes typical of glial cells (e.g., Ito et al., 1995) . Only 1 0 0 -2 0 % of the CNS cells are repo negative, and as far as we could examine, all of them have round shapes typical of neurons. Thus, the number of glial cells increases significantly under gcm ectopic expression.
We further investigated expression of a neuron-specific protein, elav. In normal embryos, all neurons, about 200 per hemisegment, express elav ( Figure 6B ; Robinow and White, 1988) , whereas glial cells do not (Xiong et al., 1994; Campbell et al., 1994) . Under gcm ectopic expression, only 10-30 cells per hemisegment, about 5%-15% of the normal number, are elav positive ( Figure 6C) . Thus, the number of elav-positive cells is reduced by 85%-95%. Most of the elav-negative cells have gila-like elongated or irregular shapes, whereas all the elav-positive cells have neuron-like round shapes. Embryos with gcm ectopic expression have much fewer axons ( Figure 6D ) compared with normal embryos (see Figure 1A) . Those remaining neurons in embryos with gcm ectopic expression ( Figure  6C and 6D) are likely those that have divided and differentiated before effective amount of gcm has accumulated.
Because gcm ectopic expression do not significantly alter the total number of CNS cells, the increase of glial cells must be at the expense of neurons. Thus, gcm ectopic expression inhibits neuronal differentiation while promoting glial differentiation. 
Pioneer Neurons Can Find Correct Pathways in gcm Mutant
In the Drosophila CNS, many glial cells are associated with axons and have been implicated to function in axonal guidance (e.g., reviewed by Goodman and Doe, 1993) . To elucidate glial functions in axonal tract formation, we investigated axonal behavior in g c m mutant. The longitudinal glial cells have been proposed to have functions in guiding the pioneer neurons, which extend the first axons in the longitudinal pathway (e.g., Jacobs, 1993 ; also reviewed by Goodman and Doe, 1993) . We investigated axonal behavior of pioneer neurons using the anti-fasciclin II antibody (G. Helt and C. S. Goodman, personal communication) . At early stage 13 in normal embryos, the anteriorly extending axon of a fasciclin II-positive pioneer neuron, pCC, reaches the adjacent anterior segment (arrows in Figure 7A ). Slightly later, the MP1 neuron, another fasciclin II-positive pioneer neuron, extends its descending axon in the longitudinal pathway (data not shown). In g c m mutants, longitudinal glial cells do not exist since the lacZ-positive presumptive glial cells (see Figure 3F ) fail to migrate to form the longitudinal array (see Figure 4D ). However, pCC axons reach the next segments in most cases (arrows in Figure 7B ). The MP1 neurons also extend their axons normally slightly later than the pCC axons (data not shown). Thus, these pioneer neurons can find their correct pathways even in the absence of the longitudinal glial cells.
Since insect glial cells have also been implicated for motor nerve formation (Bastiani and Goodman, 1986 ; also reviewed by Goodman and Doe, 1993) , we investigated the behavior of the axons that pioneer motor nerves. In a normal embryo, axons of the motoneurons exit CNS in two nerves, the segmental nerve (arrow in Figure 7C ) and the intersegmental nerve (arrowhead in Figure 7C ). The anti-fasciclin II antibody stains many of the motor axons, including the axons of the aCC neurons, which pioneer the intersegmental nerve (arrowheads in Figure 7A ). We found that the aCC axons extend almost normally in the mutant (arrowheads in Figure 7B ), indicating they can find their correct pathway without glial cells.
Although pathfindings of the pioneer neurons appear normal, g c m mutants have serious defects in axonal tract formation at later stages. At stage 16, when CNS development is almost complete, the anti-fasciclin II antibody stains two to three discrete bundles in the longitudinal connectives ( Figure 7C ). The pCC axons are included in the most medial MP1 pathway. In the g c m mutant, the fasciclin II-positive bundles are often interrupted and appear defasciculated ( Figure 7D ). The second medial-most FN3 pathway often show misroutings to lateral directions (open arrows in Figure 7D) .
The g c m mutants also show defects in the formation of motor nerves. In g c m mutant embryos ( Figure 7D Figure 7D ) or as only one thick bundle(closed circle in Figure 7D ). In normal embryos, the segmental nerve and the intersegmental nerve make a contact at the margin of the neuromere (exit junction; asterisk in Figure 7C ). In gcm mutants, even when two nerves are formed, they often do not make a contact; instead, they go up the body wall independently (arrow and open arrowhead in Figure 7D ). Even with these abnormalities, almost the same number of axons finally leave the CNS and go up the lateral body wall as in normal embryos.
Discussion
Gcm Functions as a Binary Switch between Neuronal and Glial Determination
We have isolated a Drosophila mutant, gcm, that showed serious defects in axon bundle formation. The isolation and sequencing of gcm cDNA revealed that gcm encodes a novel protein with a distinct nuclear targeting signal. We showed that gcm is expressed transiently in all glial cells except in the mesectodermal midline gila. Expression of gcm mRNA coincides closely with gliogenesis as it begins at early stage 11 and then fades during stage 12.
We investigated glial cell fate in the mutant using the enhancer detector gene lacZ on the gcm p mutant chromosome, which is expressed in the glial cells in normal heterozygous embryos. In homozygous mutant embryos, the number and initial locations of the lacZ-positive cells are normal, indicating glial cell divisions are almost normal. But most of these mutant glial cells fail to express a gilaspecific protein, repo, indicating that they have defects in glial differentiation. They also show defects in cell migration. To our surprise, these mutant cells begin to send out axons in a stereotyped manner. These results strongly suggest that in gcm mutants, presumptive glial cells differentiate into neurons.
We investigated the effect of gcm ectopic expression in the CNS using the GAL4-UAS system that is driven by the sca gene promoter. Under gcm ectopic expression, most of the CN S cells became repo positive, while number of elav-positive neurons decreased at least by 85% with concomitant reduction of axons. Thus, gcm ectopic expression promotes glial differentiation while inhibiting neuronal differentiation.
From these results, we conclude that glial/neuronal determination in Drosophila is governed by a single molecule, gcm. All CNS cells are originally bipotential so that they can differentiate into both neurons and glial cells, with neuronal differentiation as a default. They differentiate into neurons when gcm is absent, while they differentiate into glial cells when gcm is present.
Under gcm ectopic expression, most CNS cells differentiate into glial cells. We consider that virtually no cells have intermediate characteristics between neurons and gila from the following reasons. First, cells negative for both elav and repo must be very small in number, if there are any at all, since repo-negative cells are only 100--20% in number, and they all have neuron-like round shapes, whereas most of elav-negative cells have gila-like morphology. Second, similarly, cells positive for both elav and repo must be very small in number, if there are any at all, since elav-positive cells are only 5%-15% in number, and they all have neuron-like round shapes, whereas most of repo-positive cells have gila-like morphology. These results strongly suggest that gcm essentially functions in an all-or-none manner. Thus, we propose that gcm acts as a binary switch in neuronal/glial determination.
Differentiation of Individual Glial Cells
Once determined to either a neuronal or glial fate, each cell differentiates into a cell with unique individual characteristics, e.g., cell shape, location, or axonal extension pattern. In gcm mutants, presumptive glial cells differentiate into neurons. By examining the behavior of more than 21 cells among 25 transformed cells per hemisegment, we conclude that patterns of their cell migration, axonal extension, and fasciculation are highly reproducible not only from individual to individual, but also from segment to segment with minor difference between thoracic and abdominal segments. This indicates that each individual glial cell is transformed into a neuron with unique characteristics. This can be explained by assuming that mechanisms that specify glial identity can also control cellular characteristics under abnormal differentiation into neurons. Thus, we would like to suggest that neurons and glial cells share a common molecular mechanism for their identity determ ination and th at this mechanism is independent of glial/neuronal determination mediated by gcm. Several genes, such as orthodenticle (otd), fushi tarazu (ftz), and pros, are expressed in the subsets of both neurons and glial cells and are required for their development (Finkelstein et al., 1990; Doe et al., 1988 Doe et al., , 1991 . These genes are good candidates for the components of such a common identity determination mechanism. This mechanism may also be shared by m uscles, since several molecules are expressed in specific subsets of both neurons and muscles to determine their specific interactions (Chiba et al., 1995; Nose et al., 1994) .
In the PNS, we obtained results highly consistent with those in the CNS. The two genes gcm and repo are expressed in the same PNS glial cells, such as ligament cells, the support cells of dorsal bipolar dendritic cell, and peripheral glial cells (Xiong et al., 1994; Campbell et al., 1994; Halter et al., 1995; this paper) . In gcm mutants, repo expression in these cells is not detected. The mutant ligament cells have round shapes typical of neurons, and they often express a neuron-specific protein, elav, indicating their transformation into neurons. These results indicate that gcm also controls neuronai/glial determination in the PNS in a similar manner as in the CNS.
In the chordotonal organ, gcm is expressed in the ligament cells, but is not expressed in the other two glial cells, the cap cell and the scolopale. Thus, cell fate determination of these cells must depend on other molecules. A gene called sanpodo is shown to be involved in the determination between scolopale and neuron (Salzberg et al., 1994) . In the chordotonal organ, gcm most likely functions in neuronal/glial decision or glial identity specifications (or both) in combination with other genes. Involvement of other genes in neuronal/glial decision may explain the lower frequency of gila-to-neuron transformation in the mutant PNS than in the CNS.
Among glial cells in the CN S, midline glial cells are different from other glial cells in many aspects. They are derived from mesectoderm and express neither gcm nor repo. In gcm mutants, midline glial cells appear normal, indicating gcm is not essential for their development. Thus, the mesectoderm-derived cells have different mechanisms for neuronal/glial determination, which is independent of gcm. This mechanism may be controlled, at least partly, by a segmentation gene engrailed(en), since en is required for correct glial/neuronal determination in grasshopper midline cells (Condron et al., 1994) .
At the postembryonic stage, we detected the expression of gcm enhancer detector lacZ in the larval optic lobe primordia, suggesting that gcm also functions in gliogenesis in the larval brain. Gcm may also function in glial/neuronal determination in the adult PNS, since neurogenesis and gliogenesis appear to be coupled in the wing discs (Giangrande et al., 1993; Giangrande, 1994) .
Glial Functions in Axonal Tract Formation
In the Drosophila CNS, many glial cells are associated with axon bundles and have been implicated to be involved in nerve tract formation (e.g., reviewed by Goodman and Doe, 1993) . In particular, the longitudinal glial cells have been considered to be important for axonal extension and guidance, since the pioneer neurons extend along them ). However, we have shown that pCC and MP1 pioneer neurons extend their axons apparently normally in the longitudinal direction in gcm mutants. Thus, some guidance mechanisms other than the longitudinal glial cells must lead these pioneer neurons to the correct longitudinal pathway. Glial cells have also been considered to be required for the pathfinding of motoneurons (Bastiani and Goodman, 1986) . However, in gcm mutants, the pioneer axons for the intersegmental nerve leave the CNS apparently normally and then extend to the lateral direction. At later stages, almost normal numbers of axons leave the CNS to go up the lateral body wall. Therefore, it is strongly suggested that some guidance mechanisms other than glial cells lead these motoneurons to the lateral direction.
Although pioneer neurons behave apparently normally, the mutant shows serious axonal defects at later stages. Both CNS axonal tracts and motor nerves show defasciculation and misroutings. These results suggest that although glial cells are dispensable for the early pathfinding of a small number of pioneer neurons, they have essential supportive functions in the correct tract formation of the majority of axons. Since these nerve tracts are associated with a number of glial cells in normal embryos, their defects in the mutants can be caused by loss of pathfinding cues or extension support supplied by the glial cells. On the other hand, the axonal defects can also be caused by the secondary abnormality in neurons, since glial cells have functions in development and maintenance of neurons (Klaes et al., 1994; Buchanan and Benzer, 1993) . To elucidate glial functions in more detail, it is necessary to analyze the phenotypes with individual glial cell eliminations.
Gcm Is a Novel Protein That Controls Major Cell Fate Decision
We have demonstrated the remarkable functions of gcm gene, but we do not know its mode of action. Gcm has no known motifs other than the nuclear targeting sequence. Its activity must lead to transcriptional regulation of a number of genes since gcm determines cell fate between two distinct cell types, neuron and glia. In this paper we have shown that gcm ectopic expression induces expression of repo, indicating that gcm activity can lead to transcriptional activation. We have also shown that gcm ectopic expression inhibits elav expression and the formation of axons, suggesting that gcm activity can lead to transcriptional inhibition.
The mechanism of the transcriptional regulation by gcm can be direct or indirect. Since gcm is most likely a nuclear protein, we prefer the possibility that gcm is involved directly in transcriptional regulation. Two possibly functional features are found in gcm. One is the cysteine-rich region, which may bind metal to constitute a DNA-binding domain. The other is the highly basic region in the N-terminal half of the protein, which may function in interactions with nucleic acids. Supposing that gcm is a direct transcriptional regulator or a transcription factor, repo and elav are good candidates for its target genes.
Gcm is a novel regulatory protein that functions as a binary switch in a critical bifurcation point in the nervous system development. A similar or homologous molecule may also play an essential role in the vertebrate nervous system, where such binary cell fate decisions also take place, including glial/neuronal determination from a common precursor.
Experimental Procedures Enhancer Detector Screening
In our laboratory 100 lethal mutant strains were established by insertion of the P elements HZ and PZ (Mlodzik and Hiromi, 1992) into the second and the third chromosomes of ry strain with the wild-type CS background using the standard protocol (Bier et al., 1989; Bellen et al., 1989) . They were first balanced with balancer chromosomes CyO and TM3. Embryos of these balanced stocks were stained for lacZ activity. Among them, gcm p was shown to express lacZ activity in a small subset of cells in the embryonic CNS. Prior to phenotype analysis, gcm P was balanced on a balancer chromosome en'CyO, which carries a/acZ gene expressed in the pattern of segment polarity gene wing/ess. This lacZ gene was used to distinguish embryos with the balancers from homozygous mutant embryos in subsequent analyses. In vivo excision of the P element was carried out as described (Bellen et al., 1989) .
Antibody Staining
Antibody staining was done as described by Ito et al. (1995) , except that stained embryos were mounted in 90% glycerol. Staining for lacZ activity was carried out essentially according to the protocol of Kl&mbt et al. (1991) .
Working concentrations and references or sources of the primary antibodies were anti-HRP antibody (1:100; Cappel), MAb BP102 (1:100; generated by A. Bieber and N. Patel in the Goodman laboratory), antibody against RK2 (repo) (1:3000; Campbell et al., 1994) , anti-pros antibody MR1A (1:100, generated in the Doe laboratory), anti-I~-galactosidase (1:1000; Cappel), anti-elav antibody 9F8A9 (1:5; O 'Neill et al., 1994) , anti-cpo antibody (1:100; Bellen et al., 1992) , anti-fasciclin II antibody MAb 1 D4 (1:100; generated by G. Helt in the Goodman laboratory).
Molecular Cloning
All procedures for molecular cloning were essentially according to the standard protocols (Sambrook et al., 1989) . For in situ hybridization to polytene chromosomes, see Masai et al. (1993) and references therein.
Genomic libraries of the CS strain and the gcmP/CyO strain were constructed with the ZFIXII kit (Stratagene). From the library of gcm~/ CyO strain, a genomic DNA fragment adjacent to the insertion point of the P element was obtained using the 5' half of the/acZ gene as a probe. This fragment was used to screen the wild-type genomic library to obtain several clones, spanning the 20 kb around the P element insertion. They were digested with Hindlll or Xbal to be subcloned into the polycloning site of a plasmid vector pBluescript II SK(-) (Stratagene). These clones were further divided by digestion and used as probes to test embryonic expression both by Northern blot analysis and in situ hybridization. Both analysis detected only one transcription unit adjacent to the P element insertion. This region was used as a probe to screen 2 × 10 s pfu of an embryonic cDNA library (3-12 hr AEL; made in Kornberg laboratory) to obtain 11 clones. One genomic clone and the two longest cDNA clones, clone 1 and clone 9, were sequenced in both directions using the Exolll deletion procedure and Sequenase II kit (U. S. Biochemicals). Homology search was carried out with the FASTA program (Pearson and Lipman, 1988) in GenBank.
In Situ Hybridization to Embryos
In situ hybridization with digoxigenin-labeled antisense RNA probes was done essentially as described by Masai et al. (1993) . Genomic DNA fragments and cDNA clones were subclonad into pBluescript II SK(-) (Stratagene) and then used as templates for RNA probe production using the DIG-RNA labeling kit (Boehringer Mann heim). For mRNA expression assay in the mutant, eggs of gcmVen~CyO flies were collected and stained for lacZ activity as described by Kl~mbt et al. (1991) . Embryos were then devitellinated and subjected to further steps o1 in situ hybridization. Mutant homozygous embryos (gcml/gcm ') were distinguished from embryos with balancers (gcmVen 'CyO, en~lCyO/ en'~CyO) by the absence of/acZ expression.
Ectopic Expression Using the GAL4-UAS System
The gcm gene was ectopically expressed in all the embryonic neuroblasts and their progeny using the GAL4-UAS system (Brand and Perrimon, 1993) . The MluI-Aflll fragment of gcm cD NA clone 9, which contains the entire coding region plus about 100 bp of 5' and 200 bp of 3' untranslated regions, was blunt-ended and inserted into the bluntended EcoRI site of the pUAST vector to form the P[UAS-gcm] construct. This construct was introduced into white flies by germline transformation according to the standard protocol (Spradling, 1986 ) to establish six UAS-gcm lines. These lines were either balanced or made homozygous and then crossed to scaGAL lines (Klaes et al., 1994) .
